|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||||||||||
| Trade receivables and other | ||||||||||||||
| Inventories | ||||||||||||||
| Other financial assets | ||||||||||||||
| Total current assets | ||||||||||||||
| Property, plant and equipment | ||||||||||||||
| Goodwill | ||||||||||||||
| Intangible assets | ||||||||||||||
| Deferred tax assets | ||||||||||||||
| Total non-current assets | ||||||||||||||
| Assets of disposal group classified as held for sale | ||||||||||||||
| Total Assets | ||||||||||||||
| Trade payables and other | ||||||||||||||
| Borrowings | ||||||||||||||
| Other financial liabilities | ||||||||||||||
| Income tax payable | ||||||||||||||
| Provisions | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Pension and other post-employment benefit obligations | ||||||||||||||
| Deferred tax liabilities | ||||||||||||||
| Total non-current liabilities | ||||||||||||||
| Liabilities of disposal group classified as held for sale | ||||||||||||||
| Total Liabilities | ||||||||||||||
| Share capital | ||||||||||||||
| Share premium | ||||||||||||||
| Assets | ||||||||||||||
| Current assets | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Trade receivables and other, net | ||||||||||||||
| Inventories | ||||||||||||||
| Fair value of derivative instruments and other financial assets | ||||||||||||||
| Total current assets | ||||||||||||||
| Non-current assets | ||||||||||||||
| Property, plant and equipment, net | ||||||||||||||
| Goodwill | ||||||||||||||
| Intangible assets, net | ||||||||||||||
| Deferred tax assets | ||||||||||||||
| Trade receivables and other, net | ||||||||||||||
| Fair value of derivative instruments | ||||||||||||||
| Total non-current assets | ||||||||||||||
| Total assets | ||||||||||||||
| Liabilities | ||||||||||||||
| Current liabilities | ||||||||||||||
| Trade payables and other | ||||||||||||||
| Current portion of long-term debt | ||||||||||||||
| Fair value of derivative instruments | ||||||||||||||
| Income tax payable | ||||||||||||||
| Pension and other benefit obligations | ||||||||||||||
| Provisions | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Non-current liabilities | ||||||||||||||
| Trade payables and other | ||||||||||||||
| Long-term debt | ||||||||||||||
| Fair value of derivative instruments | ||||||||||||||
| Pension and other benefit obligations | ||||||||||||||
| Provisions | ||||||||||||||
| Deferred tax liabilities | ||||||||||||||
| Total non-current liabilities | ||||||||||||||
| Total liabilities | ||||||||||||||
| Shareholders' equity | ||||||||||||||
| Ordinary shares, par value €0.02, 146,819,884 shares issued at June 30, 2026 and at December 31, 2025; 135,527,728 and 135,424,702 shares outstanding at June 30, 2026 and at December 31, 2025, respectively | ||||||||||||||
| Additional paid in capital | ||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||
| Retained earnings and other reserves | ||||||||||||||
| Equity attributable to equity holders of Constellium | ||||||||||||||
| Total Equity and Liabilities | ||||||||||||||
| Retained earnings | ||||||||||||||
| Treasury shares 11,292,156 at June 30, 2026 and 11,395,182 at December 31, 2025 | ||||||||||||||
| Equity attributable to equity holders of Constellium SE | ||||||||||||||
| Non-controlling interests | ||||||||||||||
| Total equity | ||||||||||||||
| Total equity and liabilities | ||||||||||||||
Loading...